MedTrace Logo

PRevention of INteractions Between Phytotherapies and CancEr Treatments by a SmartphonE/Tablet Automated SurvEy

NCT04128865 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-10-16

No results posted yet for this study

Summary

The use of phytotherapies or specific food or dietary supplement (HFDS) is common among cancer patients. They can also be responsible of clinically relevant interaction with anti-cancer treatments. This study aims at assessing the proportion patients using HFDS which are likely to have an interaction with their anticancer treatments. The data is collected through a smartphone/tablet application. The aim of the study is to demonstrate that clinically significant herb-drug interaction with anticancer treatment could be avoid using these devices.

Conditions

Sponsors & Collaborators

  • Paul Gougis

    lead OTHER

Principal Investigators

  • Olivier Mir, MD-PhD · Gustave Roussy, Cancer Campus, Grand Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-13
Primary Completion
2019-11-10
Completion
2019-11-11

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04128865 on ClinicalTrials.gov